248 related articles for article (PubMed ID: 28953429)
1. Overactive Bladder Symptoms in Female Health Profession Students: Bladder Diary Characteristics and Impact of Symptoms on Health-Related Quality of Life.
Reisch R; Rutt R; Dockter M; Sanders S
J Womens Health (Larchmt); 2018 Feb; 27(2):156-161. PubMed ID: 28953429
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, risk factors, and impact on health related quality of life of overactive bladder in China.
Wang Y; Xu K; Hu H; Zhang X; Wang X; Na Y; Kang X
Neurourol Urodyn; 2011 Nov; 30(8):1448-55. PubMed ID: 21826714
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of overactive bladder symptoms and their impact on health-related quality of life of medical and dentistry students: a multicenter cross-sectional study.
Shawahna R; Hijaz H; Jallad K; Abushamma M; Sawafta M
BMC Urol; 2021 Oct; 21(1):142. PubMed ID: 34625087
[TBL] [Abstract][Full Text] [Related]
4. The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS.
Coyne KS; Sexton CC; Kopp ZS; Ebel-Bitoun C; Milsom I; Chapple C
BJU Int; 2011 Nov; 108(9):1459-71. PubMed ID: 21371240
[TBL] [Abstract][Full Text] [Related]
5. Is there a difference between women with or without detrusor overactivity complaining of symptoms of overactive bladder?
Giarenis I; Mastoroudes H; Srikrishna S; Robinson D; Cardozo L
BJU Int; 2013 Aug; 112(4):501-7. PubMed ID: 23452071
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of persons with overactive bladder of presumed neurologic origin: results from the Boston Area Community Health (BACH) survey.
Hall SA; Curto TM; Onyenwenyi A; Lemack GE; Tennstedt SL; Link CL; McKinlay JB
Neurourol Urodyn; 2012 Sep; 31(7):1149-55. PubMed ID: 22674347
[TBL] [Abstract][Full Text] [Related]
7. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
[TBL] [Abstract][Full Text] [Related]
8. Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study.
Lee KS; Yoo TK; Liao L; Wang J; Chuang YC; Liu SP; Chu R; Sumarsono B
BMC Urol; 2017 Nov; 17(1):108. PubMed ID: 29162085
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and effect on health-related quality of life of overactive bladder in older americans: results from the epidemiology of lower urinary tract symptoms study.
Sexton CC; Coyne KS; Thompson C; Bavendam T; Chen CI; Markland A
J Am Geriatr Soc; 2011 Aug; 59(8):1465-70. PubMed ID: 21718275
[TBL] [Abstract][Full Text] [Related]
10. Impact of solifenacin on diary-recorded and patient-reported urgency in patients with severe overactive bladder (OAB) symptoms.
Serels SR; Toglia MR; Forero-Schwanhaeuser S; He W
Curr Med Res Opin; 2010 Oct; 26(10):2277-85. PubMed ID: 20707767
[TBL] [Abstract][Full Text] [Related]
11. Comparison of body composition and overactive bladder symptoms in overweight female university students.
Hagovska M; Švihra J; Buková A; Horbacz A; Dračková D; Švihrová V
Eur J Obstet Gynecol Reprod Biol; 2019 Jun; 237():18-22. PubMed ID: 31003045
[TBL] [Abstract][Full Text] [Related]
12. Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double-blind, placebo-controlled EIGHT trial.
Chapple C; Schneider T; Haab F; Sun F; Whelan L; Scholfield D; Dragon E; Mangan E
BJU Int; 2014 Sep; 114(3):418-26. PubMed ID: 24552358
[TBL] [Abstract][Full Text] [Related]
13. The effect of caffeinated versus decaffeinated drinks on overactive bladder: a double-blind, randomized, crossover study.
Wells MJ; Jamieson K; Markham TC; Green SM; Fader MJ
J Wound Ostomy Continence Nurs; 2014; 41(4):371-8. PubMed ID: 24988515
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladder.
Ginsberg D; Schneider T; Kelleher C; Van Kerrebroeck P; Swift S; Creanga D; Martire DL
BJU Int; 2013 Aug; 112(3):373-85. PubMed ID: 23826844
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of probable overactive bladder, associated risk factors and its effect on quality of life among Turkish midwifery students.
Özgür Yeniel A; Mete Ergenoglu A; Meseri R; Hadimli A; Askar N; Mete Itil I
Eur J Obstet Gynecol Reprod Biol; 2012 Sep; 164(1):105-9. PubMed ID: 22762841
[TBL] [Abstract][Full Text] [Related]
16. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study.
Coyne KS; Sexton CC; Irwin DE; Kopp ZS; Kelleher CJ; Milsom I
BJU Int; 2008 Jun; 101(11):1388-95. PubMed ID: 18454794
[TBL] [Abstract][Full Text] [Related]
17. Impact of overactive bladder on quality of life and resource use: results from Korean Burden of Incontinence Study (KOBIS).
Lee KS; Choo MS; Seo JT; Oh SJ; Kim HG; Ng K; Lee KJ; Tan JT; Kim JC
Health Qual Life Outcomes; 2015 Jun; 13():89. PubMed ID: 26113125
[TBL] [Abstract][Full Text] [Related]
18. Effects of drug cessation after flexible-dose fesoterodine in patients with overactive bladder.
Khullar V; Cardozo L; Kelleher CJ; Hall T; Ryan J; Ebel Bitoun C; Darekar A; Arumi D; Wagg A
BJU Int; 2013 Oct; 112(6):820-9. PubMed ID: 23465055
[TBL] [Abstract][Full Text] [Related]
19. Should we use the shorter Thai-version quality of life and symptoms questionnaires in women with overactive bladder?
Bunyavejchevin S; Liao L; Lu SH; Choo MS; Rabbani KJ; Havanond P
J Obstet Gynaecol Res; 2015 Aug; 41(8):1260-5. PubMed ID: 26081949
[TBL] [Abstract][Full Text] [Related]
20. Correlation between psychological stress levels and the severity of overactive bladder symptoms.
Lai H; Gardner V; Vetter J; Andriole GL
BMC Urol; 2015 Mar; 15():14. PubMed ID: 25887525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
